Concert Study

		Check if there is a study site in your area.

		Check the study requirements.

		Call toll-free



		in the United States



		in the United Kingdom



		in Australia



		in New Zealand.

What is the Concert Study?

The Concert Study is a Phase 3 clinical research study of 1050 patients to test the effects of Dimebon in patients with Alzheimer's disease who are currently taking Aricept^® (also known as donepezil HCl tablets). The purpose of the Concert Study is to determine whether Dimebon combined with Aricept safely improves cognition (thinking and awareness), memory, daily functioning, behavior, and the ability to care for oneself.

What is Dimebon?

Dimebon is an oral medication that is being tested as a potential treatment for Alzheimer's disease.


Do you or does someone you care about have Alzheimer's and take Aricept? If so, please consider taking part in this research study. These 3 easy steps are all it takes to get started:

	Check if there is a study site in your area.

	Check the study requirements.

	Call the toll-free number in your area once you have completed steps 1 and 2:

877-888-6386 in the United States 0808 178 7958 in the United Kingdom 1-800-235-526 in Australia 0800-222-337 in New Zealand

It is important to check study locations and understand the entry requirements before discussing the Concert Study with a physician.

The Concert Study is a Phase 3 trial sponsored by Medivation, Inc, and Pfizer Inc.



	Home \| Terms of use \| Privacy policy	Aricept^® is a registered trademark of Eisai Co, Ltd. © 2009 Medivation, Inc, and Pfizer Inc. All rights reserved.